Recovery of Left Ventricular Function Three Months After Primary PCI in STEMI Patients: A Prospective Observational Study of 830 Patients
Keywords:
Ejection Fraction, LVED, PPCI, Recovery, STEMIAbstract
OBJECTIVE: To evaluate recovery of LVEF at 3 months after primary PCI and identify predictors of improvement.
METHODOLOGY: We conducted a prospective observational study of 830 consecutive STEMI patients undergoing primary PCI at SICVD Satellite centres of Larkana, Sukkur, Hyderabad and Sehwan between May and August 2025. Transthoracic echocardiography was performed within 24 hours of admission and repeated at 3 months. LVEF was measured by Simpson’s biplane method.
RESULTS: Mean age was 58±11 years, 74% were male, 36% had diabetes, and 42% had hypertension. Baseline LVEF was 42.1% ± 9.8%. At 3 months, mean LVEF improved to 47.9% ± 10.4% (mean change +5.8%, p<0.001). 68% of patients showed ?5% absolute EF recovery, while 41% improved ?10%. Predictors of greater recovery included anterior MI (?=+2.3%, p=0.02), baseline EF <40% (?=+3.5%, p<0.001), successful final TIMI 3 flow (?=+4.1%, p<0.001), and use of guideline-directed medical therapy (ACEi/ARB/ARNI and beta-blockers, both p<0.05).
CONCLUSION: In a large real-world STEMI cohort, LVEF significantly improved by 3 months after primary PCI, particularly in patients with lower baseline EF, successful reperfusion, and optimal medical therapy.
References
1. Rao SV, Morrow DA, Stone GW, Holmes DR Jr, Harrington RA, Gibson CM et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the management of patients with acute coronary syndromes. Circulation. 2025; 151(3): e1-e130.
2. Caunite L, Zibaitis A, Macaityte L, Laucevicius A. Prognostic value of follow-up measures of left ventricular function after STEMI. Cardiovasc Res. 2024; 120(5): 890-902.
3. Wu WY, Mehta SK, Chen AY, Roe MT, Wang TY. Recovery of left ventricular systolic function and clinical outcomes after myocardial infarction. J Card Fail. 2020; 26(7): 588-96.
4. Ramamirtham V, Rajendran V, Gnanavelu G. Effect of different reperfusion strategies on recovery of left ventricular function in STEMI patients. Health Sci Rep. 2024; 7(4): e2220.
5. Ndrepepa G, Kufner S, Byrne RA, Schunkert H, Fusaro M, Laugwitz KL et al. Changes in left ventricular ejection fraction after PCI and long-term mortality. J Am Heart Assoc. 2024; 13(9): e035791.
6. Oh S, Cho KH, Kim HS, Kang SH, Kim JH, Ahn Y et al. Predictors for the recovery of left ventricular ejection fraction after acute myocardial infarction: insights from the KAMIR-NIH registry. J Clin Interv. 2022; 3(1): e7.
7. Virbickiene A, Rinkuniene D, Jurkeviciene N, Grabauskaite I, Serpytis R, Aidietiene S et al. CMR predictors of left ventricular functional recovery after STEMI: CAMI-1 study. J Clin Med. 2023; 12(7): 294.
8. Shmueli H, Topilsky Y, Zahger D, Goldenberg I, Planer D. Echocardiographic predictors of left ventricular recovery in STEMI patients with baseline LVEF ?35%. J Clin Cardiol. 2024; 13(14): 4016.
9. Liu C, Zhang H, Xu J, Wang Y, Sun Q. Incidence and predictors of left ventricular function change after primary PCI in STEMI: long-term follow-up. Front Cardiovasc Med. 2023; 10: 1079647.
10. Lei Z, Chen H, Yang Y, Zhang Y, Hu J. Predictors and prognostic impact of LVEF trajectories after STEMI. BMC Cardiovasc Disord. 2022; 22(1): 237.
11. Dönmez E, Y?ld?z BS, Tüfekcioglu O, Bozbay M, Aykan AÇ. Predictors of no-reflow phenomenon in STEMI patients undergoing PCI and its relation to LVEF. Behçet’s Med Bull. 2023; 45(2): 142-50.
12. Galiuto L, Garramone B, Scarà A, Rebuzzi AG, Crea F. Microvascular dysfunction after primary PCI: impact on LV remodeling and prognosis. Circulation. 2005; 111(5): 658-63.
13. Ndrepepa G, Kufner S, Byrne RA, Schunkert H, Fusaro M, Laugwitz KL et al. Changes in left ventricular ejection fraction after PCI and long-term mortality. J Am Heart Assoc. 2024; 13(9): e035791.
14. Ottervanger JP, van ’t Hof AW, Reiffers S, Hoorntje JC, Suryapranata H, de Boer MJ et al. Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J. 2001; 22(10): 785-90.
15. Wu WY, Mehta SK, Chen AY, Roe MT, Wang TY. Recovery of left ventricular systolic function and clinical outcomes after myocardial infarction. J Card Fail. 2020; 26(7): 588-96.
16. Caunite L, Zibaitis A, Macaityte L, Laucevicius A. Prognostic value of follow-up measures of left ventricular function after STEMI. Cardiovasc Res. 2024; 120(5): 890-902.
17. Virbickiene A, Rinkuniene D, Jurkeviciene N, Grabauskaite I, Serpytis R, Aidietiene S et al. Imaging predictors of left ventricular functional recovery after STEMI via CMR. J Clin Med. 2023; 12(7): 294.
18. Galiuto L, Garramone B, Scarà A, Rebuzzi AG, Crea F. Microvascular dysfunction after primary PCI: impact on LV remodeling and long-term prognosis. Circulation. 2005; 111(5): 658-63.
19. Dönmez E, Y?ld?z BS, Tüfekcioglu O, Bozbay M, Aykan AÇ. Predictors of no-reflow phenomenon in STEMI patients undergoing PCI and its relation to LVEF. Behçet’s Med Bull. 2023; 45(2): 142-50.
20. Packer M, McMurray JJV, Desai AS, Gong J, Lefkowitz MP, Rizkala AR et al. Angiotensin receptor neprilysin inhibition compared with enalapril on LV function after MI. Lancet. 2015; 385(9972): 1844-52.
21. Køber L, Torp-Pedersen C, Carlsen J, Videbæk R, Egeblad H. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995; 333(25): 1670-6.
22. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018; 39(2): 119-77.
23. Liu C, Zhang H, Xu J, Wang Y, Sun Q. Incidence and predictors of left ventricular function change after primary PCI in STEMI: long-term follow-up. Front Cardiovasc Med. 2023; 10: 1079647.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Journal of Liaquat University of Medical & Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Submission of a manuscript to the journal implies that all authors have read and agreed to the content of the undertaking form or the Terms and Conditions.
When an article is accepted for publication, the author(s) retain the copyright and are required to grant the publisher the right of first publication and other non-exclusive publishing rights to JLUMHS.
Articles published in the Journal of Liaquat University of Medical & health sciences are open access articles under a Creative Commons Attribution-Noncommercial - Share Alike 4.0 License. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. This is in accordance with the BOAI definition of open access. In addition to that users are allowed to remix, tweak and build upon the work non-commercially as long as appropriate credit is given and the new creations are licensed under the identical terms. Or, in certain cases it can be stated that all articles and content there in are published under creative commons license unless stated otherwise.
